Access 2.8M+ Filings Sign Up Free
Gubra A/S Logo

Gubra A/S | GUBRA - Profile, Filings, Stock Info & Investor Relations Data

Gubra A/S | GUBRA
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Denmark
Founded
2008
Gubra A/S (GUBRA)

Company Profile

Website
Investor Relations

About Gubra A/S

Gubra, founded in 2008 in Denmark, is specialized in pre-clinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases. Gubra’s activities are focused on the early stages of drug development and are organised in two business areas - CRO Services and Discovery & Partnerships (D&P). The two business areas are highly synergistic and create a unique entity capable of generating a steady cash flow from the CRO business while at the same time enjoying biotechnology upside in the form of development milestone payments and potential royalties from the D&P business.

Employees

200

Market Presence

Worldwide

Headquarters

Hørsholm Kongevej 11 B
2970, Hørsholm
Denmark

Gubra A/S (GUBRA)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Gubra A/S (GUBRA)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

Gubra A/S (GUBRA)
Stock & Investor Information

ISINs

DK0062266474

LEI

254900T17RRFZONO6W53

Stock Exchange Listings

Nasdaq Copenhagen

Industry Classification

Sector
Health Care
Industry
Biotechnology